(S)-4-METHYL-3-(HYDROXYMETHYL)MORPHOLINE, 97.0%, 250mg

3-(4-Bromophenyl)cyclopentanone, 97%, 5g

Propyl 2-Furancarboxylate>97.0%(GC)25mL

Dibenzo[b,f][1,4]oxazepin-11(10H)-one, 95.0%, 1g

Thujone (alpha- and beta- mixture)>70.0%(GC)5mL

Methyl 3-(benzyloxy)-5-((2,4-difluorobenzyl)carbamoyl)-1-(2,2-dimethoxyethyl)-4-oxo-1,4-dihydropyridine-2-carboxylate, 97%, 100mg

(R)-Methyl 2-amino-3-(4-bromophenyl)propanoate hydrochloride, 98%, 10g

5-Bromo-2-methoxybenzenesulfonyl chloride, 95.0%, 5g

1-(3,4-Dimethoxyphenyl)-2-propanol, 97.0%, 10g

2',5'-Dichloro-2,2,2-trifluoroacetophenone, 95.0%, 1g

5-Methyl-1-(1-methyl-1h-pyrazol-3-yl)-1h-1,2,3-triazole-4-carboxylic acid, 95%, 50mg

2-Amino-1- o -tolyl-ethanone; hydrochloride, 1g

ethyl (2Z)-2-chloro-2-[2-(2,5-dimethylphenyl)hydrazin-1-ylidene]acetate, 95.0%, 2g